课题基金 / 基金详情

PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR

PROTECTION AGAINST APOPTOSIS BY SCATTER FACTOR
通过散射因子防止细胞凋亡
批准号:
2882849
负责人:
Eliot M. Rosen
金额:
$23.66万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-01 至 2002-02-28

项目摘要

项目成果

Eliot M. Rosen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Scatter factor (SF) or hepatocyte growth factor (HGF) is a cytokine implicated in diverse biological processes, including carcinogenesis, epithelial morphogenesis and organ repair. The applicant has found that SF can protect cultured breast cancer cells and non-tumor epithelial cells against apoptosis induced by multiple DNA damaging agents, including x-ray, UV irradiation and adriamycin leading to an increased cell survival. Protection was dependent on the expression of the c-Met proto-oncogene, the receptor for SF, but did not require functional p53. The protection seen against adriamycin may result from changes in the levels of different apoptosis regulatory proteins. The investigators hypothesize that SF mediated protection of target cells results from the transduction of a specific signal from the activated c-Met distinct from signals for motility and morphogenesis. This signal leads to downstream alterations in the levels of apoptosis regulatory proteins. By enhancing the survival of cells with genetic damage, SF may promote carcinogenesis and/or chemoradioresistance of established tumors. The applicant proposes to test these hypotheses in specific aims 1 and 2 by examining the mechanism by which SF protects epithelial and carcinoma cells against apoptosis at the levels of signal transduction from the c-Met receptor and modulation of pathways involved in apoptosis, cell cycle progression and DNA repair. In specific aim 3, an experimental animal model will be used to determine if SF can protect tumors against apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing cancer treatment by normal tissue protection
  • 批准号:
    8671485
  • 项目类别:
  • 资助金额:
    $41.15万
  • 财政年份:
    2014
  • 负责人:
    Eliot M. Rosen
  • 依托单位:
Development of BRCA1-mimetic drugs for breast cancer
  • 批准号:
    8403554
  • 项目类别:
  • 资助金额:
    $52.25万
  • 财政年份:
    2010
  • 负责人:
    Eliot M. Rosen
  • 依托单位:
Development of BRCA1-mimetic drugs for breast cancer
  • 批准号:
    8610151
  • 项目类别:
  • 资助金额:
    $52.57万
  • 财政年份:
    2010
  • 负责人:
    Eliot M. Rosen
  • 依托单位:
Development of BRCA1-mimetic drugs for breast cancer
  • 批准号:
    8022946
  • 项目类别:
  • 资助金额:
    $58.71万
  • 财政年份:
    2010
  • 负责人:
    Eliot M. Rosen
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: